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Abstract 39 
Background: Poor appetite is a marker of morbidity and mortality in hemodialysis patients, 40 
making it an important area for research. Visual analog scales (VAS) can capture a range of 41 
subjective sensations related to appetite (such as hunger, desire to eat or fullness), but have not been 42 
commonly used to measure appetite in dialysis patients. The aim of this study was to explore the 43 
association between retrospective ratings of appetite using VAS and a range of clinical variables as 44 
well as biomarkers of appetite in hemodialysis patients.  45 
Methods: 28 hemodialysis patients (mean age 61±17y, 50% male, median dialysis vintage 19.5(4-46 
101) months) rated their appetite using VAS for hunger, fullness and desire to eat and a 5-point 47 
categorical scale measuring general appetite. Blood levels of the appetite peptides leptin, ghrelin 48 
and peptide YY were also measured.  49 
Results: Hunger ratings measured by VAS were significantly (p<0.05) correlated with a range of 50 
clinical, nutritional and inflammatory markers: age (r=-0.376), co-morbidities, (r=-0.380) PG-SGA 51 
score (r=-0.451), weight (r=-0.375), fat-free mass (r=-0.435), C-Reactive Protein (CRP) (r=-0.383) 52 
and Intercellular adhesion molecule (sICAM-1) (r=-0.387). There was a consistent relationship 53 
between VAS and appetite on a 5-point categorical scale for questions of hunger, and a similar 54 
trend for desire to eat, but not for fullness. Neither method of measuring subjective appetite 55 
correlated with appetite peptides.  56 
Conclusions: Retrospective ratings of hunger on a VAS are associated with a range of clinical 57 
variables and further studies are warranted to support their use as a method of measuring appetite in 58 
dialysis patients.  59 
60 
 3
Introduction  61 
Poor appetite is reported in 30-40% of dialysis patients and is clearly and consistently associated 62 
with worse outcomes including clinical variables (lower dietary intakes, higher inflammatory 63 
markers, more malnutrition), reduced quality of life, more hospitalisations and a 4-fold increase in 64 
risk of death (Burrowes et al., 2005; Carrero et al., 2007; Kalantar-Zadeh et al, 2004; Lopes et al., 65 
2007). There is evidence that inflammation may be an underlying cause of poor appetite in dialysis 66 
patients, having effects such as decreasing gastric and intestinal motility, modifying gastric 67 
secretions and causing taste aversions (Bergstrom, 1999). Levels of appetite peptides such as leptin 68 
and ghrelin are also altered in dialysis patients (Bossola et al., 2004; Heimbürger et al 1997; Perez-69 
Fontan et al., 2004; Rodriguez Ayala et al., 2004) indicating disturbances in appetite regulation at a 70 
biological level.  71 
 72 
The poor prognosis for patients with reduced appetite means that more research is required to 73 
increase understanding of and find ways to improve this symptom. Most studies in dialysis patients 74 
have measured appetite using rating scales which ask patients to assess their appetite retrospectively 75 
on a categorical scale, for example the 5-point scale developed by Burrowes et al (1996). The 76 
concept of appetite covers a variety of subjective sensations (such as hunger, satiety, desire to eat) 77 
and asking one question about general appetite may miss these important sensations. An alternative 78 
method of measuring appetite that would allow the researcher to capture a range of aspects of 79 
appetite is by using Visual Analog Scales (VAS). These are a well established method for 80 
measuring appetite (Silverstone & Stunkard, 1968) and are commonly used in obesity research. 81 
They consist of a question followed by a horizontal line with descriptions at each end ranging from, 82 
for example, ‘not at all hungry’ to ‘as hungry as I have ever felt’ (Silverstone & Stunkard, 1968) 83 
They are often designed to capture the state of the participant at the time and the questions repeated 84 
regularly over a number of hours or days. Several authors have used VAS in dialysis patients in this 85 
way. Wright et al demonstrated disturbed appetite profiles over 24-hr periods in both hemodialysis 86 
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(2001) and peritoneal dialysis (2003b) patients. Wynne et al (2005) also used regular (half-hourly) 87 
measurements before and after a meal to measure changes in hunger, fullness, desire to eat and 88 
nausea in a randomized controlled trial of ghrelin infusion in 9 peritoneal dialysis patients. This 89 
method of repeated measuring over a short time frame is not always practical however, especially in 90 
clinical populations, as hourly measurements place a significant burden on the participant. One way 91 
to overcome this may be to frame the question so that the participant is asked to rate their feelings 92 
over the past week rather than the state at the time, so that hourly measurements are not required. 93 
No prior studies have investigated the use of this approach.   94 
 95 
The aim of this study was to test the association between retrospective ratings on a VAS (where the 96 
participant rates their appetite over the past week) and categorical methods, clinical variables 97 
(including demographic, medical, nutritional and inflammatory markers) and biomarkers of appetite 98 
(leptin, ghrelin and PYY) in hemodialysis patients.  99 
100 
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Methods 101 
Subjects 102 
The study was granted approval by the hospital and university ethics committees and informed 103 
consent was obtained from all participants. All patients at a dialysis unit of a private hospital in 104 
Brisbane, Australia were approached for recruitment. Patients were excluded if they had been on 105 
hemodialysis for less than three months or were unable to give informed consent due to intellectual 106 
impairment or mental illness impairing their ability to follow instructions. Out of 49 patients in the 107 
unit, 6 were ineligible and 15 declined to participate, resulting in a sample of 28 patients. 108 
Demographic and medical information (including age, gender, dialysis vintage, albumin measured 109 
bv Bromocresol green method) was abstracted from the medical records.  Patients were receiving 110 
hemodialysis on average three times per week. The causes of kidney disease were: 3 nephritis, 3 111 
polycystic kidney disease, 4 hypertension, 1 diabetes, 2 reflux, 7 uncertain, 3 analgesic-related, 5 112 
other. The presence and severity of co-morbidities was assessed by using the Charlson Comorbidity 113 
Index (Charlson et al, 1987) where each comorbidity receives a score and a higher total score 114 
reflects more severe comorbidities.  115 
Appetite 116 
Subjective appetite was measured during a routine hemodialysis session using two methods. There 117 
was no standardization between patients regarding whether the session was the first, midweek or 118 
last dialysis session of the week. The first was the question developed by Burrowes et al (1996) 119 
which forms part of the Appetite and Dietary Assessment Tool (ADAT) and asks patients to record 120 
their appetite over the past week using the question “During the past week, how would you rate 121 
your appetite?”. Response options are very good, good, fair, poor or very poor. This method has 122 
been validated in several large studies (Burrowes et al., 2005; Kalantar-Zadeh et al., 2004). Patients 123 
were then presented with three VAS using 100mm lines (see Appendix 1). The questions asked 124 
related to hunger (“Over the past week, in general how hungry have you been feeling?”), desire to 125 
eat (“In the past week, in general how strong has your desire to eat been?”) and fullness (“In the 126 
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past week, in general how full have you been feeling?”). The questions are weighted with the 127 
extremes at each end (0=Not at all and 100=Extremely). The VASs were administered in a single 128 
session and designed to reflect retrospective ratings of motivation to eat rather than the state at the 129 
time.  130 
 131 
Blood samples 132 
Blood samples (non-fasting) were drawn predialysis into heparinised tubes and/or vacutainers on 133 
the same day as patients completed all other testing. Plasma and serum were separated by 134 
centrifugation, aliquoted and stored at -80° until assay. The adhesion molecules Intercellular 135 
adhesion molecule (sICAM-1) and Vascular cell adhesion molecule (sVCAM-1) were measured 136 
using commercially available ELISA kits (Chemicon International, USA & Canada). The 137 
concentrations of these molecules are determined by reference to standard curves obtained by the 138 
corresponding recombinant molecule. The sensitivity of the kit for sICAM-1 was 2.17ng/mL (range 139 
6.25-100ng/mL) and for sVCAM-1 was 0.59ng/mL (range 3.2-100ng/mL). Each sample was 140 
analysed in duplicate and the average of the results used. Ultra-sensitive C-reactive protein (CRP) 141 
was assessed by a commercial laboratory on the ADVIA 2400 using the principle of latex enhanced 142 
immunoturbidimetry. Detection range of the test is to 0.1mg/L. Interleukin-6 (IL6) was analysed 143 
using a Millipore Lincoplex Assay Kit for IL6 as per manufacturer’s recommendation. The assay 144 
plate was read on a Luminex 100 instrument. The samples were read in one batch. The intra-run 145 
variation of controls was < 7%.  Ghrelin, leptin and Peptide YY (PYY) were measured using 146 
commercially available RIA kits (Linco Research, Missouri) where the concentration of the 147 
molecule is determined by reference to a standard curve obtained by known concentrations of 148 
antigen. Each sample was analysed in duplicate and the average of the results used. The kit for 149 
measuring ghrelin uses an antibody which is specific for the biologically active form of ghrelin with 150 
the octanoyl group on serine 3. The sensitivity of the kit was 7.8pg/mL. The kit for PYY measures 151 
both the 1-36 and 3-36 forms of Human PYY. The sensitivity of the kit was 10pg/ml. The kit for 152 
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leptin utilizes 125I-labeled human leptin and a human leptin antiserum to determine the level of 153 
leptin in serum, plasma or tissue culture media by the double antibody/PEG technique. The 154 
sensitivity of the leptin kit was 0.5ng/mL.  155 
 156 
Nutritional parameters 157 
All nutritional parameters were measured during a routine hemodialysis session, on the same day as 158 
the blood samples were drawn and subjective appetite was measured. Nutritional status was 159 
assessed using subjective global assessment (SGA) (Detsky et al., 1987) and the scored Patient-160 
Generated Subjective Global Assessment (PG-SGA), both of which have been validated in dialysis 161 
patients (Desbrow et al., 2005; Steiber et al., 2004). The SGA includes a medical history (covering 162 
weight change, dietary intake, gastrointestinal symptoms and changes in functional capacity) and 163 
physical examination (assessment of muscle stores, ascites and oedema) (Detsky et al., 1987). 164 
Patients are assigned to a rating of well-nourished (A), moderately malnourished (B) or severely 165 
malnourished (C). The PG-SGA provides a score (0-4) for each section, depending on the presence 166 
of nutrition impact symptoms and metabolic stress. A physical examination is carried out as with 167 
the SGA. All of the component scores are added (0-35) with the higher the score, the greater risk of 168 
malnutrition.  Dietary intake was measured by 3 day food diary. The entries were verified with the 169 
patient by a dietitian using food models and the data analysed using Foodworks (Xyris software ver 170 
4). The procedure recommended in the evidence-based guidelines for nutritional management of 171 
chronic kidney disease (Ash et al, 2006) was used to calculate and report intake, in g/kg ideal body 172 
weight/ day protein and kJ/kg ideal body weight/day energy. Height was measured using a 173 
stadiometer (Livingstone) and weight on an electronic scale which also incorporated a foot-to-foot 174 
bioelectrical impedance analysis (BIA) machine (Tanita, model TBF-410, d=0.1kg, single 175 
frequency, 50kHZ) which was used to estimate % body fat and fat-free mass (kg). BIA 176 
measurements were taken 30 minutes post-dialysis. Arm muscle area (AMA) was calculated based 177 
on measurements of arm circumference and triceps skinfold (Curtin University of Technology, 178 
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2004) using Harpenden callipers (range 50.00mm, resolution .20mm, repeatability .20mm, accuracy 179 
99.0%).  Both BIA (Chertow et al., 1995) and skinfold measurements (Kamimura et al., 2003) have 180 
been validated against gold-standard methods of measuring body composition in dialysis patients 181 
 182 
Statistical analysis 183 
Data was analysed using SPSS for Windows ver 15.0. Descriptive statistics of the sample are 184 
presented. Correlation coefficients (Pearson normal/Spearman not normal) and associated 185 
significance level were used to assess the relationship between the VAS and other variables. VAS 186 
scores were normally distributed and ANOVA was used to compare the responses on the ADAT 187 
tool with scores on the VAS and appetite peptides.  Statistical significance was set at the traditional 188 
p<0.05 level.  189 
190 
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Results 191 
Baseline characteristics 192 
The mean(SD) age of the sample was 61(17) years and 50% were male. Patients had been on 193 
dialysis for a median (range) of 19.5(4-101) months and the median (range) Charlson Comorbidity 194 
Index was 2.5(2-7). All patients were well nourished according to subjective global assessment 195 
(100% SGA A) (Table 1).  However, mean (SD) dietary intakes of 95.7(22.1)kJ/kg/day energy and 196 
1.1(0.21)g/kg/day of protein were below guideline recommendations for hemodialysis patients 197 
(>125kJ/kg/day energy and 1.2-1.4g/kg/day protein) (Ash et al., 2006) (Table 1).  198 
 199 
Mean (SD) ratings on the VAS were 51(23)mm for hunger ratings, 51(18)mm for fullness and 200 
52(22)mm for desire to eat. Appetite on a categorical scale was sub-optimal in 25% of the sample (5 201 
fair, 2 poor) despite all being well nourished.  Due to the low numbers of participants rating appetite 202 
as fair/poor, these categories were combined in subsequent analyses. 13 patients rated their appetite 203 
as good and 8 as very good.  204 
 205 
Agreement between categorical scale and VAS  206 
Table 2 shows the relationship between ratings of appetite on a categorical scale and VAS ratings 207 
for hunger, desire to eat and fullness. Ratings for hunger showed a linear pattern indicating that as 208 
patients’ self-reported appetite progressed from very good to fair/poor, they also tended to rate 209 
lower on a VAS. The differences in mean score were also statistically significant. Ratings of desire 210 
to eat showed a similar linear pattern and the scores were similar to hunger although the difference 211 
did not reach statistical significance in this sample. The relationship appears to be less consistent 212 
when asking about fullness as ratings did not show a linear pattern corresponding to appetite status.  213 
 214 
Relationship between VAS and clinical variables 215 
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Significant correlations occurred between hunger ratings and the nutritional parameters weight (kg), 216 
% body fat, PG-SGA as well as the inflammatory markers CRP and sICAM-1 (Table 3). Hunger 217 
ratings had a significant negative correlation with age and the Charlson Comorbidity Index although 218 
not with dialysis vintage. There was no relationship between hunger ratings and dietary intake or 219 
albumin and no significant relationships between ratings of desire to eat and fullness with any of the 220 
variables (data not shown).  221 
 222 
Appetite peptides 223 
There were no relationships between hunger ratings and levels of the appetite peptides leptin, 224 
ghrelin or PYY. There was also no significant difference between the average level of any of the 225 
peptides according to appetite assessed on a categorical scale (Table 4).  226 
227 
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Discussion 228 
This is the first study to explore the association between appetite measured by retrospective hunger 229 
ratings on a VAS with a range of clinical variables and appetite peptides in CKD patients. The main 230 
findings of this study were that ratings of hunger were associated with nutritional (PG-SGA, 231 
weight, fat-free mass) and inflammatory (CRP, sICAM-1) markers, that there was a consistent 232 
relationship between VAS and categorical methods and that neither method of assessing subjective 233 
appetite was associated with the appetite peptides leptin, ghrelin or PYY.  234 
 235 
Several studies have established that hemodialysis patients’ appetite assessed by categorical 236 
methods is associated with a range of clinical variables including worse nutritional status and higher 237 
inflammatory markers (Burrowes et al., 2005; Carrero et al., 2007; Kalantar-Zadeh et al., 2004; 238 
Lopes et al., 2007) . When using hourly measurements of hunger, desire to eat, fullness and 239 
tiredness on an electronic VAS, Wright et al (2001) did not find any correlations with markers of 240 
nutritional status (including BMI, SGA, CRP and albumin) in hemodialysis patients, although there 241 
were some correlations in the control group. Therefore this is the first study to demonstrate that 242 
retrospective ratings of hunger over the past week on a VAS (as opposed to repeated measurements 243 
of the state at the time) correlate with nutritional and inflammatory markers in hemodialysis 244 
patients, in a manner similar to that found when using categorical methods. 245 
 246 
Hunger ratings were significantly related to PGSGA score, even though all the patients were 247 
classified as well nourished (SGA category A). The PGSGA does not ask patients to rate their 248 
appetite but the presence of a reduction in appetite (“no appetite, just did not feel like eating”) is 249 
scored if reported by the patient.  The tool also covers a range of other issues which may affect the 250 
patients’ appetite and food intake such as the presence of vomiting, dry mouth, taste alterations, 251 
problems swallowing or mouth sores. The significant association between the two indicates that 252 
there is a close relationship between a decline in hunger and even small reductions in nutritional 253 
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status and supports the importance of appetite assessment as part of clinical practice to detect 254 
patients at early risk of malnutrition. 255 
 256 
Adhesion molecules (including sICAM-1 and sVCAM-1) are markers of both inflammation and 257 
cardiovascular damage, as they play a role in binding white blood cells to the endothelium in the 258 
early stages of plaque development (van de Stolpe & van der Saag, 1996). In this study hunger 259 
ratings were significantly associated with CRP and sICAM-1. No prior studies have measured the 260 
association between appetite and adhesion molecules. A relationship between poor appetite and 261 
raised CRP has been found when using categorical methods of measuring appetite in hemodialysis 262 
patients (Carrero et al., 2007; Kalantar-Zadeh et al., 2004) Therefore this study shows for the first 263 
time that appetite measured using retrospective ratings of hunger on a VAS correlates with 264 
inflammatory markers in a manner similar to that found when using categorical methods. This 265 
strengthens the case for a potential role of inflammation, including the adhesion molecules, in the 266 
pathogenesis of anorexia in CKD.  267 
 268 
Hunger ratings were found to be significantly lower with increasing age and with higher co-269 
morbidities. Prior studies which have used categorical methods of appetite assessment in CKD have 270 
not found any relationship between age and appetite (Burrowes et al., 2005; Carrero et al., 2007; 271 
Kalantar-Zadeh et al., 2004; Lopes et al., 2007) . Reductions in appetite are commonly reported in 272 
the general elderly population, referred to as ‘age-related anorexia’ (Chapman, 2007).  This 273 
indicates that hunger ratings by VAS may be more sensitive to age-related reductions in appetite 274 
than categorical methods. Some previous studies using categorical methods have also found 275 
relationships between self-reported appetite and the presence of co-morbidities (Burrowes et al., 276 
2005; Kalantar-Zadeh et al., 2004).  277 
 278 
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We found no relationship between hunger ratings and dialysis vintage or number of hours dialysis 279 
per week. Carrero et al (2007) found a significant trend towards higher dialysis vintage as appetite 280 
worsened (more pronounced in men) although Kalantar-Zadeh et al (2004) found a trend towards 281 
lower dialysis vintage as appetite worsened. Burrowes et al (2005) and Ohri-Vachaspati et al (1999) 282 
found no relationship between appetite and dialysis vintage. These results show a large intra-283 
individual variation in the response to ongoing dialysis and indicate that the length of time on 284 
dialysis is not necessarily a reliable predictor of appetite status (Carrero, 2009). 285 
 286 
There was no significant association between retrospective hunger ratings over the past week and 287 
dietary intake. A review of the use of VAS (Stubbs et al., 2000) to assess subjective appetite 288 
sensations at the time of measurement also found that the correlations between appetite and energy 289 
intake are low, and that subjectively rated hunger appears to be a valid predictor of approximate 290 
meal size and frequency, but a poor predictor of energy intake (Stubbs et al., 2000). Under-291 
reporting of dietary intakes may have an effect on this relationship. In dialysis patients, several 292 
studies have shown estimated rates of under-reporting of approximately 60-70% of patients (Fasset 293 
et al 2007; Kloppenburg et al, 2002). The low associations found between hunger and energy intake 294 
in this study do not invalidate the use of VAS, but merely mean that, for example, a low hunger 295 
rating over the past week should not necessarily be equated to low energy intake over the past week. 296 
This finding may explain why there was a negative correlation between hunger ratings and fat-free 297 
mass, when one would expect people who report feeling hungrier to be eating more and therefore to 298 
have a higher fat-free mass. The amount of fat-free mass is affected by various other factors 299 
including gender, amount of exercise undertaken and medical/nutritional factors such as the 300 
presence of protein-energy wasting, which may lead to loss of muscle mass in dialysis patients 301 
(Avesani et al., 2006). Hunger ratings are associated with nutritional status as well as inflammatory 302 
markers and therefore can be a useful way of measuring the effect of a nutrition intervention, 303 
irrespective of their ability to predict dietary intake.  304 
 14
 305 
There was no significant relationship between the appetite peptides leptin, ghrelin and PYY and 306 
subjective methods of measuring appetite, either categorical or using VAS. Other authors have also 307 
reported this. Bossola et al (2004) reported no differences in serum leptin levels between anorexic 308 
and non-anorexic hemodialysis patients. Wright et al (2003a) found no relationship between VAS 309 
and the peptide cholecystokinin in hemodialysis patients but did find relationships in peritoneal 310 
dialysis patients. Chang et al (2007) found no association between serum ghrelin levels and scores 311 
on a VAS in dialysis patients. This has also been reported in cancer patients (Garcia et al., 2005) 312 
and may be due to alterations in normal neural and hormonal control of appetite in disease states. 313 
Also, the strong associations found between these molecules, particularly leptin, with fat mass 314 
(Heimbürger et al., 1997), may mean they are not major contributors to anorexia in dialysis patients, 315 
particularly in the presence of protein-energy wasting, which may result in loss of fat mass and 316 
therefore override the contribution of the peptides to appetite.   317 
 318 
This study found that the VAS was associated with the categorical method for hunger and desire to 319 
eat, as patients who reported better appetite tended to rate higher on the VAS while those who 320 
reported worse appetite rated lower. The lack of statistical significance for desire to eat likely 321 
reflects the small sample size as the actual values and pattern were similar to that for hunger ratings. 322 
These results indicate that there is some consistency between the two methods, although the 323 
relationship was less consistent for fullness. This may indicate that asking a single question about 324 
appetite does not necessarily capture all aspects of subjective appetite such as feelings of fullness. 325 
The objective of this study was not concerned with validating the VAS against the ADAT tool. 326 
However, these results indicate that there is some association between the two methods and provide 327 
a positive clinical application that VAS would be a useful tool for measuring appetite in renal 328 
patients.  329 
 330 
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A strength of this study is that hunger ratings have been compared to a range of other variables 331 
including categorical methods as well as novel markers of inflammation (sICAM-1 and sVCAM-1) 332 
and biomarkers of appetite (leptin, ghrelin and PYY). There are several limitations to the study. 333 
Retrospective ratings of hunger on a VAS over the past week were measured and this means that 334 
the results are not comparable to studies which have used VAS to repeatedly measure the state of 335 
participants at the time. Furthermore, this study has simply examined the association between this 336 
method and other clinical variables; it has provided evidence about validity. There were no patients 337 
in the sample who rated their appetite as very poor and relatively few who rated as poor. This has 338 
also been found in prior studies (Burrowes et al., 2005; Carrero et al., 2007; Kalantar-Zadeh et al., 339 
2004). In this study, it means that the agreement found between the categorical scale and VAS may 340 
not hold at the lower end of the scale. The relationships found may also differ in patients who are 341 
malnourished. Previous studies have found gender differences in appetite in hemodialysis patients 342 
(Carrero et al., 2007) and this could also be explored in larger samples using this method.  343 
 344 
This study has shown that retrospective hunger ratings (but not ratings of desire to eat or fullness) 345 
are associated with nutritional parameters and inflammatory markers and are mostly consistent with 346 
categorical methods. This method offers the advantage of having a lower participant burden than 347 
traditional VAS administered hourly and appears to be a feasible method of measuring appetite. It 348 
would provide a practical and useful alternative assessment tool to simply enquiring about appetite 349 
in patients with chronic conditions. However, further studies in larger samples would be required to 350 
confirm these findings and explore the possibility of gender differences in the hemodialysis 351 
population.   352 
 353 
  354 
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Appendix 1 Example of Visual Analog Scales 
For the following questions, please place a mark along the line in the position that best represents 
your feelings.  
 
During the past week, in general how hungry have you been feeling? 
 
 
  
Not at all hungry      Extremely hungry 
 
 
During the past week, in general how full have you been feeling? 
 
 
 
Not at all full       Extremely full 
 
 
During the past week, in general how strong has your desire to eat been? 
 
 
 
Not at all strong      Extremely strong 
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Table 1: Characteristics of hemodialysis patients (n=28)  
Parameter Mean  SD  
Nutritional   
PGSGA score 1 (0-7)† 
BMI, kg/m2 27.4  7.2 
Arm Muscle Area (cm2) 45.7  19.1 
% fat 30.4  12.2 
Fat-free mass, kg 52.7  10.7 
Energy intake  (kJ/kg IBW/day) 95.6  22.1 
Protein intake (g/kg IBW/day) 1.1  0.2 
Inflammation  
C-reactive Protein, mg/L 2.5 (0.1-76)† 
Albumin, g/L 40.9  3.5 
Interleukin-6, pg/mL 3.0 (0.3-60.6)† 
sICAM-1, ng/mL 270  80 
sVCAM-1, ng/mL 1714  660 
Appetite peptides  
Leptin, ng/mL 26 (2-200)† 
Ghrelin, pg/mL 106  63 
PYY, pg/mL 642  166  
† median (range) 
Abbreviations: PGSGA=Patient-Generated Subjective Global Assessment; BMI=Body Mass Index; sICAM-1= soluble 
intercellular adhesion molecule; sVCAM-1=soluble vascular cell adhesion molecule; PYY=Peptide YY 
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Table 2: Association between appetite rating using ADAT score and mean  SD VAS score for 
ratings of hunger, desire to eat and fullness 
 
 
ADAT score 
Very good 
n=8 
 
Good 
n=13 
 
Fair/poor 
n=7 
 
p value* 
VAS score 
Hunger, mm 
 
66  17 
 
52  23 
 
34  20 
 
0.025 
Desire to eat, mm 63  18 53  25 40  15 0.129 
Fullness, mm 59  13 42  19 58  16 0.061 
*ANOVA 
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Table 3: Relationship between ratings of hunger on a VAS and demographic variables, nutritional 
status, inflammation and appetite peptides in hemodialysis patients (n=28).  
 Correlation 
coefficient 
Significance 
Demographics   
Age -.376 0.049 
Dialysis vintage* .151 0.443 
CCI Index* -.380 0.046 
Inflammation   
Albumin .252 0.197 
C-reactive Protein* -0.383 0.04 
Interleukin-6 0.129 0.513 
sICAM-1 -0.387 0.042 
sVCAM-1 -0.293 0.131 
Nutritional parameters   
Energy intake (kJ/kg/day) .278 0.169 
Protein intake (g/kg/day) -.037 0.857 
PGSGA score* -.451  0.016 
Weight (kg) -.375 0.049 
BMI -.219 0.264 
Arm Muscle Area -.331 0.106 
Fat-free mass -.435 0.026 
% fat .015 0.941 
Appetite peptides   
Leptin 0.117 0.551 
Ghrelin 0.052 0.796 
PYY 0.178 0.366 
* Spearman correlation. Abbreviations: CCI=Charlson Comorbidity Index; sICAM-1= soluble intercellular adhesion 
molecule; sVCAM-1=soluble vascular cell adhesion molecule; PGSGA=Patient-Generated Subjective Global 
Assessment; BMI=Body Mass Index; PYY=Peptide YY 
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Table 4: Relationship between self-reported appetite using ADAT score and appetite peptides 
 Very good 
n=8 
Good 
n=13 
Fair/poor 
n=7 
p value* 
Leptin, ng/mL, median 
(range) 
47 (8-178) 19 (2-200) 33 (6-70) 0.408 
Ghrelin, pg/mL, mean  SD 109  65 118  65 76  56 0.422 
PYY, pg/mL, mean  SD  687  186 623  136 628  208 0.692 
*ANOVA 
 
